However, the Singh brothers surprised everyone when they sold their stake in Ranbaxy at its greatest ebb to Japanese drugmaker Daiichi Sankyo in 2008 for $4.6 billion (approximately ₹59,700 crore today), ensuing much media attention, especially for the price that it fetched. They then used the proceeds from the sale to aggressively expand Fortis Healthcare.
The storied business empire that they once helmed started unravelling when accusations of siphoning money from the proceeds of the Ranbaxy sale to the Radha Soami Satsang Beas, a spiritual sect in the Radha Soami movement. The brothers are also accused of siphoning ₹500 crore from the publicly listed Fortis Healthcare. Amid mounting debts and government sleuths breathing down…
